AzTrials
AzTrials

Mobility LimitationsPhase 2ATUTINCT00927706

Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial

A Phase 2 study testing Assistive technology updating and tune up intervention in people with Mobility Limitations, run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal at 4 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effectiveness of an assistive technology updating and tune up intervention on users and their caregivers. This intervention includes 4 components: an in-residence assessment of the mobility preferences of the older person and his/her caregiver a detailed review of forms of… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Mobility Limitations
What is being tested?
Assistive technology updating and tune up intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
4 sitesCanada
Study dates
Jun 2009to Aug 2011
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Users: Aged 65 years and over
  • Have moderate to severe disability that limits their ability to move from place to place independently and/or to perform self-care activities.
  • Living at home
  • Receiving 2 or more hour per week of assistance with mobility and/or self-care activities from a non-professional, caregiver who is also willing to take part in the study.
  • Those caregivers will be adults aged 18 years and over.

Who cannot join

  • Assistive technology users will be excluded if they have severe aphasia, are currently on a community occupational therapist caseload, or are unable to communicate in English or French.

Trial locations and contacts

4 sites in 1 country.

Canada4 sites
  • Centre de santé et des services sociaux de Bordeaux-Cartierville--St-Laurent

    Montreal, Quebec

  • the Centre de santé et des services sociaux Cavendish

    Montreal, Quebec

  • the Centre de santé et des services sociaux de Laval

    Montreal, Quebec

  • Simon Fraser University

    Vancovuer, British Columbia, V6B 5K3

Other trials in Canada

About this study

Official title: Experimental Control Investigation of the Impact of an Assistive Technology Updating and Tune up Intervention on the User-caregiver Dyad: a Multi-site Trial

The purpose of this study is to determine the effectiveness of an assistive technology updating and tune up intervention on users and their caregivers. This intervention includes 4 components:

  • an in-residence assessment of the mobility preferences of the older person and his/her caregiver
  • a detailed review of forms of assistance, technological and human, that are currently being used
  • recommendations by an occupational therapist for possible changes in the older person's mobility assistive technology or assistance strategy
  • therapist negotiation of an mobility assistive technology updating and tune-up intervention plan with the individual and his or her caregiver. The intervention is provided to the immediate treatment following the administration of baseline measures and the delayed intervention group six weeks later, after an additional baseline measurement. The treatment is six weeks long and the follow-up is 26 weeks.
Read more

Hypothesis 1: For community-dwelling older people, an intervention that increases the appropriateness of existing or new assistive technology(AT) for mobility or self-care will alter established patterns of human assistance, such that caregiver burden is reduced or eliminated.

Hypothesis 2: At the same time, AT users will report less difficulty in mobility or self-care, as well as enhanced subjective well-being, and satisfaction with their modified personal assistance strategy.

Hypothesis 3: Following the AT intervention, caregivers will report reduced physical and/or psychological demands and increased satisfaction with their caregiving-related activities compared with

  • the pre-intervention period
  • caregivers in a delayed intervention control group. Hypothesis 4: Decreased physical and/or psychological demands on helpers will be associated with increases in device users' satisfaction with their personal assistance strategies.
Being tested
Assistive technology updating and tune up intervention
Keywords
Assistive Technology, Mobility Limitation, Physical Disability, Caregiver, Participation
Medical subject headings
Mobility Limitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assistive technology updating and tune up interventionDevice

    This intervention includes 4 components: 1) an in-residence assessment of the mobility preferences of the older person and his/her caregiver; 2) a detailed review of forms of assistance, technological and human, that are currently being used; 3) recommendations by an occupational therapist for possible changes in the older person's mobility assistive technology or assistance strategy; and 4) therapist negotiation of an mobility assistive technology updating and tune-up intervention plan with the individual and his or her caregiver.

Study groups in NCT00927706
Study groupRoleWhat they receive
Immediate interventionExperimentalSubjects and their caregivers randomized to this arm receive the intervention immediately after baseline data is collected.
Receives: Device: Assistive technology updating and tune up intervention
Delayed InterventionExperimentalSubjects and their caregivers who are randomized to this group will receive the intervention after baseline measurements are administered twice (6 weeks apart).
Receives: Device: Assistive technology updating and tune up intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of Life Habits

    Measured: baseline (1or 2 times), 6 weeks (immediately after intervention), 16 weeks later

  2. Caregivers: Caregiver Assistive Technology Outcome Measure

    Measured: base line (1 or 2), 6 weeks (immediately after intervention), 16 weeks later

Secondary outcomes (4)
  1. Individually Prioritized Problem Assessment

    Measured: Baseline (1 or 2 times), Immediately after intervention, 16 weeks later

  2. Functional Autonomy Measurement System

    Measured: Baseline (1 or 2 times), Immediately after intervention, 16 weeks later

  3. Psychological Impact of Assistive Devices Scale

    Measured: Imediately after intervention. 16 weeks later

  4. Satisfaction with Personal Assistance Strategy

    Measured: Baseline (1 or 2 times), Immediately after intervention, 16 weeks later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2009 (estimated)
  2. Study startJun 2009
  3. Primary completionAug 2011
  4. Study completionAug 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00927706
Sponsor's protocol ID
CRIUM-8317
Other IDs
NIDRR: H133A060062
Acronym
ATUTI
Status last verified
Feb 2014
First submitted
24 Jun 2009
Last updated
19 Feb 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Assistive technology updating and tune up intervention in people with Mobility Limitations, run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of Life Habits (time frame: baseline (1or 2 times), 6 weeks (immediately after intervention), 16 weeks later). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in